SCHEMBL7272158

SCHEMBL7272158

CN1CCCC(Oc2noc(-c3ccccc3)c2Cl)C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.44
CHRM1 P11229 2/20 0.44
CHRM3 P20309 2/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
CYP2D6 P10635 1/20 0.40
HTT P42858 1/20 0.40
USP2 O75604 1/20 0.38
USP1 O94782 1/20 0.38
USP8 P40818 1/20 0.38
OTUB1 Q96FW1 1/20 0.38
USP36 Q9P275 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
IGF1R P08069 2/20 0.38
HTR2C P28335 2/20 0.37
DRD2 P14416 1/20 0.37
HTR2A P28223 1/20 0.37
KCNH2 Q12809 1/20 0.37
HTR2B P41595 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7272809 0.99 CHRM2 (0.43) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL7272297 0.88 SMN1; SMN2 (0.41) CHRM2CHRM1CHRM3CHRM4CHRM5
Hydrochloric Acid SCHEMBL7271450 0.87 SMN1; SMN2 (0.43) CHRM2CHRM1CHRM3CHRM4CHRM5
Hydrochloric Acid SCHEMBL7272912 0.75 IKBKB (0.43) CHRM2CHRM1CHRM3KCNH2
SCHEMBL7272053 0.74 CHRM2 (0.42) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL7273106 0.74 CXCR1 (0.48) CHRM2CHRM1CHRM3CHRM4CHRM5
Hydrochloric Acid SCHEMBL7282354 0.73 CXCR1 (0.47) CHRM2CHRM1CHRM3CHRM4CHRM5
Hydrochloric Acid SCHEMBL7272563 0.73 CHRM2 (0.41) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL7279325 0.72 ALDH1A1 (0.44) L3MBTL1HTR2CHTR2B
SCHEMBL7280850 0.72 FAAH (0.44) L3MBTL1HTR2CHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5643923-A TREATMENT OF ANXIETY, COGNITION ACTIVATORS, SENILITY OR ALZHEIMER'S SANKYO COMPANY, LIMITED (JP) 1997-07-01 US disclosed
EP-0456519-B1 Piperidyloxy- and quinuclidinyloxy- isoxazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1994-07-13 EP disclosed
EP-0456519-A1 Piperidyloxy- and quinuclidinyloxy- isoxazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1991-11-13 EP disclosed